Veterinary 3D Bioprinting Market to Grow 7X to USD 2.1 Bn as Custom-Grown Organs Replace Metal Implants
[SAN DIEGO, USA – May 13th 2025] – The veterinary 3D bioprinting market is projected to grow at a CAGR of 34% to reach USD 2.1 Bn by 2031, according to a new 360-page ClearView report.
Request Sample @ https://clearviewmarketinsights.com/report-details/veterinary-3d-bioprinting-market/
Key developments:
Industry Shifts
- Clinical
Milestones:
- Vet3D's Canine Jaw
Grafts: 92% osseointegration vs. 65% for titanium.
- CollPlant's Tendon
Bioink: Enables racehorses to return 4 months earlier.
- Regulatory
Progress:
- FDA's 2026
"Veterinary Bioprinting Accelerated Pathway".
- EU bans conventional
implants for zoo animals (2028).
- Economic
Impacts:
- Pet insurance now covers
45% of bioprinting procedures.
- "Bioprinted"
pedigree dogs command 60% price premiums.
Executive Quotes
- Dr. Sarah Taylor, Vet3D CEO:
"We're printing living bone that grows with the patient—this is the end of static implants." - Yehiel Tal, CollPlant CEO:
"Our plant-based bioinks heal tendons faster than nature alone."
Future Projections
- 2028: First
bioprinted canine heart valve transplantation.
- 2030: 25%
of veterinary orthopedic procedures use bioprinting.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading
market research and consulting firm providing in-depth industry analysis and
strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
Comments
Post a Comment